HCAHCA HealthcareQ2 2026Earnings Analysis

Revenue growth driven by rate and volume plus one-time Medicaid payment recognition

Revenues increased 8.7% consolidated (9.3% same facility) to $20.230B, driven by a 6.0% increase in revenue per equivalent admission and 2.6% increase in equivalent admissions. The quarter includes $1.372B of incremental revenue and $829M of incremental other operating expenses related to the Florida Medicaid directed payment program covering Oct 2024–June 2026, approved by CMS during the quarter, of which ~$980M of revenue and $557M of expense related to prior periods.

Source: 10-Q Item 2 MD&A

Net income and EPS growth aided by share repurchases

Net income attributable to HCA Healthcare was $1.699B ($7.62 diluted EPS) versus $1.653B ($6.83 diluted EPS) in Q2 2025, a 2.8% net income increase but an 11.6% EPS increase, reflecting a reduction in diluted shares from 241.911M to 222.828M due to 7.909M shares repurchased in H1 2026 and 26.739M in 2025.

Source: 10-Q Item 2 MD&A

Rising uninsured admissions tied to EPTC expiration

Consolidated and same facility uninsured admissions increased 23.3% and 23.4% respectively versus Q2 2025, driven by the expiration of enhanced premium tax credits (EPTCs) at the end of 2025 and administrative reforms, plus attrition of Exchange volumes from Q1 into Q2. Total uncompensated care rose to $15.076B from $11.625B, with estimated cost of uncompensated care rising to $1.445B from $1.116B.

Source: 10-Q Item 2 MD&A

Operating cash flow declined sharply on working capital and tax timing

Cash flows from operating activities declined $1.875B, from $4.210B in Q2 2025 to $2.335B in Q2 2026, primarily due to $1.413B of unfavorable working capital changes (including higher accounts receivable tied to Medicaid state directed/supplemental payment programs) and a $594M increase in income taxes paid related to a 2025 IRS deferral for Tennessee-based taxpayers, partially offset by a $28M increase in underlying net income.

Source: 10-Q Item 2 MD&A

Regulatory changes to Medicaid supplemental payments and provider taxes pose future uncertainty

The 2025 Federal Budget Act (FBA) caps SDP arrangement payment rates to Medicare rates starting for rating periods on/after July 4, 2025, with grandfathered arrangements phasing down beginning January 1, 2028; CMS also issued a February 2026 final rule and proposed a July 2026 rule limiting provider tax structures, which could reduce federal Medicaid matching funds and negatively affect reimbursement.

Source: 10-Q Item 2 MD&A

The FBA mandates CMS to cap SDP payment rates at Medicare levels (instead of average commercial rates) for rating periods beginning on/after July 4, 2025, with grandfathered arrangements subject to phase-down starting January 1, 2028. HCA is unable to predict the timing or extent of future CMS approvals or the amount of resulting revenue recognition, creating uncertainty around a material revenue source (Florida directed payment program alone added $1.372B in Q2 2026).

Source: 10-Q Item 2 MD&A

The FBA restricts provider tax arrangements used to fund the non-federal share of Medicaid programs, and CMS issued a final rule (February 2026) and a proposed rule (July 2026) implementing limits on provider tax structure and safe harbor limits. Some existing taxes on managed care organizations and providers must be reduced or eliminated subject to transition periods, which could reduce state Medicaid funding and negatively affect reimbursement rates.

Source: 10-Q Item 2 MD&A

The expiration of enhanced premium tax credits (EPTCs) at the end of 2025 drove a 23.3%-23.4% increase in uninsured admissions and pushed total uncompensated care to $15.076B in Q2 2026 (from $11.625B), with estimated cost of uncompensated care rising to $1.445B. Continued erosion of Exchange-based coverage could further pressure payer mix and collections.

Source: 10-Q Item 2 MD&A

Operating cash flow declined $1.875B year-over-year to $2.335B, driven by $1.413B of unfavorable working capital changes (notably higher receivables tied to Medicaid state directed/supplemental payment programs) and a $594M increase in income taxes paid due to a prior-year IRS deferral for Tennessee taxpayers. This illustrates sensitivity of near-term liquidity to government payment program timing and tax deferral reversals.

Source: 10-Q Item 2 MD&A

103 hospitals in Texas and Florida generated 58% of admissions and 55% of revenues in Q2 2026, and 73% of uninsured admissions came from these two states, concentrating exposure to state-specific Medicaid policy, natural disaster, and economic risks.

Source: 10-Q Item 2 MD&A